StonvexLoading…
StonvexStonvexStonvexCore line items from ORMP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $2.00M | $2.00M | $2.00M | $2.00M |
Operating Income | $-15.09M | $-9.42M | $-6.99M | $-4.50M |
Net Income | $64.05M | $54.04M | $5.65M | $-7.64M |
EPS (Diluted) | $1.50 | $1.26 | $0.13 | $-0.19 |
Total Assets | $230.86M | $220.49M | $161.68M | $147.54M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $45.95M | $52.18M | $15.80M | $74.52M |
Free Cash Flow OCF − CapEx | $-9.15M | $-8.69M | $-7.06M | $-3.52M |
Shares Outstanding | 39.28M | 40.84M | 40.85M | 40.85M |